Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology
- 15 November 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 32 (6) , 1619-1623
- https://doi.org/10.1016/s0735-1097(98)00403-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.Circulation, 1994
- Recent changes in the management and outcome of acute closure after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1993
- Changing incidence and management of abrupt closure following coronary intervention in the new device eraCatheterization and Cardiovascular Diagnosis, 1992
- Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profileJournal of the American College of Cardiology, 1992
- A Comparison of Angioplasty with Medical Therapy in the Treatment of Single-Vessel Coronary Artery DiseaseNew England Journal of Medicine, 1992
- Clinical trials of restenosis after coronary angioplasty.Circulation, 1991
- Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.Circulation, 1990
- Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.Circulation, 1990
- Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.Circulation, 1988
- Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 PatientsJournal of the American College of Cardiology, 1988